OFG
AZN icon

OmniStar Financial Group’s AstraZeneca AZN Stock Holding History

OmniStar Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-295
Closed -$26K – 125
2020
Q1 		$26K Buy
+295
New +$27.8K 0.03% 163

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

OmniStar Financial Group's AZN Position: Q2 2020 in Review

OmniStar Financial Group sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 295 shares — an estimated $26K sold.

OmniStar Financial Group first reported a position in AZN in Q1 2020 and held it in 1 quarter. The position peaked at $26K in Q1 2020. 668 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • OmniStar Financial Group reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
  • OmniStar Financial Group sold 295 AstraZeneca shares in Q2 2020, an estimated $26K.
  • OmniStar Financial Group first reported a position in AstraZeneca in Q1 2020 and held it in 1 quarter.
  • OmniStar Financial Group's AstraZeneca position peaked at $26K in Q1 2020.
  • 668 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on OmniStar Financial Group's 13F filing for Q2 2020, filed 6 Jul 2020.